BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20511555)

  • 1. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
    Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
    J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
    von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
    Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
    Latham KA; Whittington KB; Zhou R; Qian Z; Rosloniec EF
    J Immunol; 2005 Apr; 174(7):3978-85. PubMed ID: 15778354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
    Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
    Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D; Hill JA; Cairns E; Bell DA
    J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
    Kimata M; Cullins DL; Brown ML; Brand DD; Rosloniec EF; Myers LK; Stuart JM; Kang AH
    Arthritis Res Ther; 2012 May; 14(3):R107. PubMed ID: 22569209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
    J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
    Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
    Catalano A
    J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of collagen arthritis.
    Brand DD; Kang AH; Rosloniec EF
    Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic autoreactive B cells are not negatively selected toward matrix protein collagen II.
    Cao D; Khmaladze Ia; Jia H; Bajtner E; Nandakumar KS; Blom T; Mo JA; Holmdahl R
    J Immunol; 2011 Nov; 187(9):4451-8. PubMed ID: 21940677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
    Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
    Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
    Tada Y; Koarada S; Morito F; Ushiyama O; Haruta Y; Kanegae F; Ohta A; Ho A; Mak TW; Nagasawa K
    Arthritis Rheum; 2003 Nov; 48(11):3280-90. PubMed ID: 14613294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.
    Nissim A; Winyard PG; Corrigall V; Fatah R; Perrett D; Panayi G; Chernajovsky Y
    Arthritis Rheum; 2005 Dec; 52(12):3829-38. PubMed ID: 16329077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.